Lung Cancers Completed Phase 2 / 3 Trials for Cediranib (DB04849)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00245154Paclitaxel and Carboplatin With or Without Cediranib Maleate in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerTreatment